home All News open_in_new Full Article

Triple dose of Novo Nordisk drug delivers 19% weight loss in trials

Danish pharma group seeks to broaden options and stay competitive with Eli Lilly


today 35 h. ago attach_file Events

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Society
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics


ID: 441922584
Add Watch Country

arrow_drop_down